St. Jude (STJ) Shares Sink as FDA Receives Report Linking Durata to Cable Defect

June 12, 2012 12:27 PM EDT Send to a Friend
Shares of St. Jude (NYSE: STJ) are plunging midday as Bloomberg is reporting the FDA has received a report linking the company's Durata wire to a cable defect. The report pointed to a single case of an external wire.

The stock is now down 2.6 percent to $37.54.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Hot FDA News, Momentum Movers

Add Your Comment